Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer

Authors

Keywords

Journal

Volume -, Issue -, Pages 1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2019-05-30

DOI

10.1097/cji.0000000000000275

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started